|
DNAJC18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.70039995604088E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.82429999995293E-08 |
| Normal-vs-Stage2 |
5.035600E-03 |
| Normal-vs-Stage3 |
4.042600E-04 |
| Normal-vs-Stage4 |
3.368300E-04 |
| Stage1-vs-Stage2 |
6.234200E-01 |
| Stage1-vs-Stage3 |
8.752200E-01 |
| Stage1-vs-Stage4 |
6.563000E-01 |
| Stage2-vs-Stage3 |
7.914400E-01 |
| Stage2-vs-Stage4 |
5.297600E-01 |
| Stage3-vs-Stage4 |
6.546000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11190000540162E-08 |
| Normal-vs-AfricanAmerican |
1.35290000002897E-06 |
| Normal-vs-Asian |
2.939700E-03 |
| Caucasian-vs-AfricanAmerican |
8.135600E-01 |
| Caucasian-vs-Asian |
8.201400E-01 |
| AfricanAmerican-vs-Asian |
7.660600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39810385491046E-11 |
| Normal-vs-Female |
4.139000E-03 |
| Male-vs-Female |
2.803200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.74324999999698E-05 |
| Normal-vs-Extreme_Weight |
8.7249000246814E-09 |
| Normal-vs-Obese |
2.28489999998249E-06 |
| Normal-vs-Extreme_Obese |
6.38490000000047E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.807800E-01 |
| Normal_Weight-vs-Obese |
7.183000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.190200E-01 |
| Extreme_Weight-vs-Obese |
9.418000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.006800E-01 |
| Obese-vs-Extreme_Obese |
5.344800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.978900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.65758999999266E-05 |
| Normal-vs-Age(61-80Yrs) |
1.8994994466226E-10 |
| Normal-vs-Age(81-100Yrs) |
3.69320000004336E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.795200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.710000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.643000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.111560E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.777800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.011200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.08980047208718E-10 |
| Normal-VS-Type2 PRCC |
1.93290999999096E-05 |
| Normal-VS-KIRP CIMP |
5.66240387911421E-11 |
| Normal-VS-Unclassified PRCC |
1.509230E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.246750E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.231110E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.184300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.55799999971229E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.512180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.68060000005354E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.22519999490711E-08 |
| Normal-vs-N1 |
2.798700E-04 |
| Normal-vs-N2 |
4.278800E-03 |
| N0-vs-N1 |
7.522000E-01 |
| N0-vs-N2 |
9.510000E-01 |
| N1-vs-N2 |
8.537000E-01 |
|
|
